Impress employers and recruiters.
Choose from hundreds of resume examples.
Impress employers and recruiters.
Choose from hundreds of resume examples.
Target Resume Now
About the Role
Support the strategy, planning, and execution of commercial assessments for AI-enabled pipeline programs. This high-impact role reports to the Director of New Product Planning.
Responsibilities
- Analyze disease areas, treatment paradigms, and unmet needs to shape the positioning of new potential drugs.
- Support KOL interviews and secondary research to build and validate commercial assumptions.
- Track competitor pipelines, clinical readouts, approvals, and deals, translating implications into updated assumptions.
- Contribute commercial input into Target Product Profiles (TPPs) and clinical development plans.
- Collaborate with cross-functional teams to align programs with commercial objectives.
Requirements
- Life sciences background, ideally a BS or MS degree in biology or a related field.
- 1-2 years at a top-tier consulting firm, investment bank, or equity research group preferred.
- Experience in New Product Planning, marketing, portfolio strategy, competitive intelligence, or a related analytical role at a pharmaceutical or biotech company also considered.
- Experience in oncology or immunology is a plus.
- Some exposure to commercial assessments based on primary and secondary research, ideally for preclinical and early clinical assets.
- Strong Excel modeling and PowerPoint skills.
- Excellent communication, listening, and presentation skills.
- Ability to travel domestically and internationally, if required, approximately 10% of the time.
Skills
- Excel modeling
- PowerPoint
- Communication
- Listening
- Presentation
Location
- San Diego
Work Type
- Onsite
Experience Level
- 1-2 years
Education Level
- BS or MS degree in biology or a related field
About the Company
- Genesis Molecular AI is pioneering foundation models for molecular AI to unlock a new era of drug design and development.
- Our generative and predictive AI platform, GEMS (Genesis Exploration of Molecular Space), integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction.
- Genesis is backed by premier AI and life science investors, including a16z, NVIDIA, Rock Springs Capital, Menlo Ventures, T. Rowe Price, Fidelity, and Radical Ventures.
- Genesis has also signed category-leading AI-pharma deals, the most recent of which was a significant expansion with Incyte with a total potential deal value of several billion dollars.
- Genesis is headquartered in San Mateo, CA, with a fully integrated laboratory in San Diego.
Equal Opportunity
- We are proud to be an inclusive workplace and an Equal Opportunity Employer.